At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
Stimulation will be delivered at with different microdosing setting to identify the optimal parameter values for each patient.device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
BurstDR™ micrOdosing stimuLation in De-novo Patients
In Brief
A clinical study evaluating Stimulation will be delivered at with different microdosing setting to identify the optimal parameter values for each patient. for Pain, Intractable and Pain, Back. Completed, enrolled 60 participants across 5 sites.
Detailed Summary
The purpose of this study is to evaluate the therapeutic efficacy of microdosing BurstDR stimulation in spinal cord stimulation (SCS) patients with chronic intractable back and/or leg pain.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Intractable, Pain, Back
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartOct 2017
First PostedNov 2017
Primary CompletionJul 2019
TodayJul 2026
First PostedNov 22, 2017
Enrollment StartOct 30, 2017
Primary CompletionJul 2, 2019
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 8.6 years ago
Interventions
Stimulation will be delivered at with different microdosing setting to identify the optimal parameter values for each patient.device
BurstDR spinal cord stimulation will be delivered with different ON/OFF periods to identify the best setting for each patients.